Cited by 208Menopause: Health Impacts and TreatmentsHormonal and reproductive studiesDiabetes, Cardiovascular Risks, and Lipoproteins

Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study

Open access
Ding, E. L., Song, Y., Manson, J. E., Rifai, N., Buring, J. E., Liu, S.·2007·Diabetologia

Abstract

Aims/hypothesis Prospective data directly investigating the role of endogenous sex hormones in diabetes risk have been scant, particularly in women. We aimed to examine comprehensively plasma sex hormones in connection with risk of developing type 2 diabetes in postmenopausal women.Methods We conducted a prospective, nested case-control study of plasma oestradiol, testosterone and dehydroepiandrosterone sulfate and risk of type 2 diabetes in a cohort of women health professionals with a mean age of 60.3 and 12.2 years since menopause. Among women not using hormone therapy and free of baseline cardiovascular disease, cancer and diabetes, 359 incident cases of type 2 diabetes were matched with 359 controls during an average follow-up of 10 years.Results Oestradiol and testosterone were each strongly and positively associated with risk of type 2 diabetes. After adjustment for BMI, family history, lifestyle and reproductive variables, the multivariable relative risks (95% CI) comparing the highest vs lowest quintile were 12.6 (2.83-56.3) for total oestradiol (p = 0.002 for trend), 13.1 (4.18-40.8) for free oestradiol (p < 0.001 for trend), 4.15 (1.21-14.2) for total testosterone (p = 0.019 for trend) and 14.8 (4.44-49.2) for free testosterone (p < 0.001 for trend). These associations remained robust after adjusting and accounting for other metabolic syndrome components and baseline HbA(1c) levels.Conclusions/interpretation In postmenopausal women, higher plasma levels of oestradiol and testosterone were strongly and prospectively related to increased risk of developing type 2 diabetes. These prospective data indicate that endogenous levels of sex hormones may play important roles in the pathogenesis of type 2 diabetes. ClinicalTrials.gov ID no.: NCT00000479.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-007-0785-y

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ding, E. L., Song, Y., Manson, J. E., Rifai, N., Buring, J. E., & Liu, S.
Affiliations
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
Corresponding author
  • Ding, E. L.
  • Liu, S.
Venue
Diabetologia
Published
2007-08-14
Volume
50
Issue
10
Pages
2076-2084
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2134314425
Cited by
208
References
59
Citations by year
2026: 2 · 2025: 8 · 2024: 13 · 2023: 13 · 2022: 13 · 2021: 11 · 2020: 11 · 2019: 9 · 2018: 6 · 2017: 18 · 2016: 13 · 2015: 14 · 2014: 12 · 2013: 8 · 2012: 14
FWCI
8.04
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • Brigham and Women's Hospital
  • National Institutes of Health (5r01hl043851-10)
  • National Heart, Lung, and Blood Institute (HL43851)
  • National Cancer Institute (CA-47988, R01CA047988)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK066401, R01DK066401)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, sex hormones, estradiol, testosterone, dehydroepiandrosterone sulfate, postmenopausal women, endogenous sex hormones, diabetes risk
MeSH terms
Aspirin, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Double-Blind Method, Estradiol, Female, Glycated Hemoglobin, Humans, Middle Aged, Risk Factors, Testosterone, Vitamin E, Body Mass Index, Postmenopause, Dehydroepiandrosterone Sulfate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review